{
     "PMID": "28625590",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20170814",
     "LR": "20180218",
     "IS": "1090-2430 (Electronic) 0014-4886 (Linking)",
     "VI": "295",
     "DP": "2017 Sep",
     "TI": "Intranasal cotinine improves memory, and reduces depressive-like behavior, and GFAP+ cells loss induced by restraint stress in mice.",
     "PG": "211-221",
     "LID": "S0014-4886(17)30155-3 [pii] 10.1016/j.expneurol.2017.06.016 [doi]",
     "AB": "Posttraumatic stress disorder (PTSD), chronic psychological stress, and major depressive disorder have been found to be associated with a significant decrease in glial fibrillary acidic protein (GFAP) immunoreactivity in the hippocampus of rodents. Cotinine is an alkaloid that prevents memory impairment, depressive-like behavior and synaptic loss when co-administered during restraint stress, a model of PTSD and stress-induced depression, in mice. Here, we investigated the effects of post-treatment with intranasal cotinine on depressive- and anxiety-like behaviors, visual recognition memory as well as the number and morphology of GFAP+ immunoreactive cells, in the hippocampus and frontal cortex of mice subjected to prolonged restraint stress. The results revealed that in addition to the mood and cognitive impairments, restraint stress induced a significant decrease in the number and arborization of GFAP+ cells in the brain of mice. Intranasal cotinine prevented these stress-derived symptoms and the morphological abnormalities GFAP+ cells in both of these brain regions which are critical to resilience to stress. The significance of these findings for the therapy of PTSD and depression is discussed.",
     "CI": [
          "Copyright (c) 2017 Elsevier Inc. All rights reserved."
     ],
     "FAU": [
          "Perez-Urrutia, Nelson",
          "Mendoza, Cristhian",
          "Alvarez-Ricartes, Nathalie",
          "Oliveros-Matus, Patricia",
          "Echeverria, Florencia",
          "Grizzell, J Alex",
          "Barreto, George E",
          "Iarkov, Alexandre",
          "Echeverria, Valentina"
     ],
     "AU": [
          "Perez-Urrutia N",
          "Mendoza C",
          "Alvarez-Ricartes N",
          "Oliveros-Matus P",
          "Echeverria F",
          "Grizzell JA",
          "Barreto GE",
          "Iarkov A",
          "Echeverria V"
     ],
     "AD": "Universidad San Sebastian, Facultad de Ciencias de la Salud, Lientur 1457, Concepcion 4030000, Chile. Universidad San Sebastian, Facultad de Ciencias de la Salud, Lientur 1457, Concepcion 4030000, Chile. Universidad San Sebastian, Facultad de Ciencias de la Salud, Lientur 1457, Concepcion 4030000, Chile. Universidad San Sebastian, Facultad de Ciencias de la Salud, Lientur 1457, Concepcion 4030000, Chile. Universidad San Sebastian, Facultad de Ciencias de la Salud, Lientur 1457, Concepcion 4030000, Chile. Department of Psychology, NeuroNET Research Center, University of Tennessee, Knoxville, TN 37996, USA. Departamento de Nutricion y Bioquimica, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogota D.C., Colombia; Instituto de Ciencias Biomedicas, Universidad Autonoma de Chile, Santiago, Chile. Universidad San Sebastian, Facultad de Ciencias de la Salud, Lientur 1457, Concepcion 4030000, Chile. Electronic address: Alexandre.Iarkov@uss.cl. Universidad San Sebastian, Facultad de Ciencias de la Salud, Lientur 1457, Concepcion 4030000, Chile; Instituto de Ciencias Biomedicas, Universidad Autonoma de Chile, Santiago, Chile; Bay Pines VA Healthcare System, Research and Development, Bay Pines, 33744, FL, USA. Electronic address: valentina.echeverria@uss.cl.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20170615",
     "PL": "United States",
     "TA": "Exp Neurol",
     "JT": "Experimental neurology",
     "JID": "0370712",
     "RN": [
          "0 (Glial Fibrillary Acidic Protein)",
          "0 (glial fibrillary astrocytic protein, mouse)",
          "K5161X06LL (Cotinine)"
     ],
     "SB": "IM",
     "MH": [
          "Administration, Intranasal",
          "Animals",
          "Astrocytes/drug effects/pathology",
          "Brain Chemistry/drug effects",
          "Cotinine/administration & dosage/*therapeutic use",
          "Depression/*drug therapy/etiology/psychology",
          "Glial Fibrillary Acidic Protein/metabolism",
          "Male",
          "Memory Disorders/*drug therapy/etiology/psychology",
          "Mice",
          "Mice, Inbred C57BL",
          "Motor Activity/drug effects",
          "Recognition (Psychology)/drug effects",
          "Restraint, Physical",
          "Stress, Psychological/complications/*drug therapy/psychology",
          "Swimming/psychology"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "*Astrocytes",
          "*Cotinine",
          "*Depression",
          "*Memory",
          "*Stress"
     ],
     "EDAT": "2017/06/20 06:00",
     "MHDA": "2017/08/15 06:00",
     "CRDT": [
          "2017/06/20 06:00"
     ],
     "PHST": [
          "2017/03/27 00:00 [received]",
          "2017/06/09 00:00 [revised]",
          "2017/06/12 00:00 [accepted]",
          "2017/06/20 06:00 [pubmed]",
          "2017/08/15 06:00 [medline]",
          "2017/06/20 06:00 [entrez]"
     ],
     "AID": [
          "S0014-4886(17)30155-3 [pii]",
          "10.1016/j.expneurol.2017.06.016 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Exp Neurol. 2017 Sep;295:211-221. doi: 10.1016/j.expneurol.2017.06.016. Epub 2017 Jun 15.",
     "term": "hippocampus"
}